Rituximab labelling of CLL cells alone increased PBMC NK cell degranulation; however, reovirus treatment significantly increased NK cell CD107a/b degranulation compared with rituximab alone (Figure 5b). The gene discussed is LAMP1; the disease is B-cell chronic lymphocytic leukemia.